EyePoint Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results Release Date and Conference Call Information
Oct 30, 2018
|
EyePoint Pharmaceuticals Appoints John Landis, Ph.D., M.S., to Board of Directors
Oct 30, 2018
|
EyePoint Pharmaceuticals Presents Positive YUTIQ™ 24-month Follow-up Data at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting
Oct 29, 2018
|
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ to be Presented at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting
Oct 18, 2018
|
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
Oct 15, 2018
|
EyePoint Pharmaceuticals Announces Proceeds of $28.9 Million from Exercised Warrants
Oct 01, 2018
|
EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress
Sep 12, 2018
|
EyePoint Pharmaceuticals Elects Göran Ando, M.D. as Next Chairman of Board of Directors
Sep 10, 2018
|
EyePoint Pharmaceuticals Secures Pass-through Payment Status and Assignment of C-Code for DEXYCU™
Sep 05, 2018
|
EyePoint Pharmaceuticals Announces Fiscal 2018 Fourth Quarter & Full Year Financial Results Release Date and Conference Call Information
Sep 05, 2018
|
EyePoint Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 28, 2018
|
EyePoint Pharmaceuticals Appoints John Weet, Ph.D., as SVP, Regulatory Affairs & Quality
Aug 15, 2018
|
EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 03, 2018
|
EyePoint Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference
Aug 02, 2018
|
EyePoint Pharmaceuticals Appoints David Price as Chief Financial Officer
Aug 01, 2018
|
EyePoint Pharmaceuticals Announces Presentation of Data Highlighting YUTIQ™ for Posterior Segment Uveitis at the 36th Annual Scientific Meeting of the American Society of Retina Specialists
Jul 25, 2018
|
EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ™ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists
Jul 11, 2018
|
EyePoint Pharmaceuticals Appoints Göran Ando, M.D., to Board of Directors
Jun 26, 2018
|
EyePoint Pharmaceuticals Announces Stockholder Approval of Second Tranche of Capital Financing
Jun 25, 2018
|
EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.
May 16, 2018
|